|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-1-29
|
|
pubmed:abstractText |
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in the United States in February 2000. The PROTEKT US study evaluated serotype distribution, PCV7 coverage and antimicrobial susceptibility among Streptococcus pneumoniae isolates collected from children aged 0 to 14 years in 2000 through 2001 (year 1; n = 2033), 2002 through 2003 (year 3; n = 1740) and 2003 through 2004 (year 4; n = 1591).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0891-3668
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
123-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17259873-Adolescent,
pubmed-meshheading:17259873-Anti-Bacterial Agents,
pubmed-meshheading:17259873-Child,
pubmed-meshheading:17259873-Child, Preschool,
pubmed-meshheading:17259873-Drug Resistance, Bacterial,
pubmed-meshheading:17259873-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:17259873-Humans,
pubmed-meshheading:17259873-Infant,
pubmed-meshheading:17259873-Infant, Newborn,
pubmed-meshheading:17259873-Meningococcal Vaccines,
pubmed-meshheading:17259873-Microbial Sensitivity Tests,
pubmed-meshheading:17259873-Pneumococcal Infections,
pubmed-meshheading:17259873-Pneumococcal Vaccines,
pubmed-meshheading:17259873-Serotyping,
pubmed-meshheading:17259873-Streptococcus pneumoniae,
pubmed-meshheading:17259873-United States
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
|
|
pubmed:affiliation |
G. R. Micro Ltd, London, UK.
|
|
pubmed:publicationType |
Journal Article
|
